9 Treatment Options for Heavy Perimenopausal Bleeding That Are Not Just 'Wait and See'
The number of women who describe flooding through clothes at work, cancelling plans, or sleeping on towels because they were told their bleeding was 'just perimenopause' is genuinely heartbreaking. Heavy bleeding is not a rite of passage to white-knuckle through — it is a medical symptom with real treatments. Knowing the options exists is the first step to actually getting one.
Learn more about Rose →Levonorgestrel-Releasing Intrauterine System (LNG-IUS / Mirena)
The levonorgestrel IUS is consistently the most effective non-surgical treatment for heavy menstrual bleeding, reducing blood loss by 70–95% in most users within the first year. It works by delivering progestogen directly to the uterine lining, causing it to thin significantly, and it doubles as contraception — which matters in perimenopause when pregnancy is still possible. NICE guidelines list it as the first-line long-term treatment for heavy menstrual bleeding without an identified structural cause, and it can also form the progestogen component of HRT.
Tranexamic Acid
Tranexamic acid is a non-hormonal tablet taken during the heaviest days of a period that reduces blood loss by around 40–50% by preventing the breakdown of blood clots in the uterus. It does not affect cycle regularity or hormone levels, making it a practical option for women who cannot or do not want to use hormonal treatments. It is available on prescription and, in some countries, over the counter, and it works best when taken at the first sign of heavy flow rather than reactively.
Norethisterone (Oral Progestogen)
Norethisterone is a synthetic progestogen prescribed either cyclically to regulate and lighten periods or continuously to stop bleeding temporarily — useful for managing flooding before a more permanent solution is in place. Taken at higher doses (5mg three times daily from days 5–26 of the cycle), it can meaningfully reduce blood loss, though it is less effective than the LNG-IUS and some women find the side effects, including low mood and bloating, difficult to tolerate. It is often used as a short-term bridge while waiting for other interventions, and micronised progesterone is increasingly preferred by some clinicians for women who are also using HRT.
Combined Oral Contraceptive Pill (COCP)
The combined pill is a well-established treatment for heavy perimenopausal bleeding, reducing blood loss by up to 50% and offering the additional benefit of cycle regulation and contraception. It works by suppressing ovulation and thinning the endometrial lining, and can also ease associated symptoms such as cramping and perimenopausal mood fluctuations in some women. It is not appropriate for everyone — those with migraines with aura, certain cardiovascular risk factors, or who smoke over the age of 35 should discuss alternatives — but for eligible women it remains a practical and reversible option.
Progesterone-Based HRT
For women who are already on or considering HRT for other perimenopausal symptoms, the progestogen component — taken in adequate doses and for sufficient days of the cycle — can significantly reduce heavy bleeding. Sequential HRT regimens that include at least 12–14 days of progestogen per cycle are associated with better endometrial protection and lighter withdrawal bleeds than shorter courses. Micronised progesterone (body-identical progesterone) is increasingly favoured for its more favourable side effect profile and is associated with better tolerability than synthetic progestogens in many women.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
NSAIDs such as mefenamic acid and naproxen reduce blood loss by approximately 25–35% when taken during menstruation by inhibiting prostaglandins, the compounds that promote uterine contractions and increase vascular permeability in the endometrium. They are non-hormonal, available on prescription, and also address the painful cramping that often accompanies heavy perimenopausal periods. While less effective than tranexamic acid or the LNG-IUS, they are a useful option for women who prefer short-term, as-needed intervention without hormonal exposure.
Endometrial Ablation
Endometrial ablation is a minor surgical procedure that destroys the lining of the uterus using heat, microwave energy, or other methods, with the goal of reducing or stopping periods altogether. Around 80% of women report significantly lighter periods following the procedure and up to 35% experience complete cessation of bleeding; it is typically performed under local or general anaesthetic as a day case. It is not appropriate for women who wish to preserve fertility, and it does not provide contraception — pregnancy after ablation is rare but carries serious risks, so reliable contraception remains essential.
GnRH Analogues (Temporary Medical Menopause)
Gonadotrophin-releasing hormone (GnRH) analogues such as leuprorelin or goserelin work by suppressing ovarian hormone production, inducing a temporary menopausal state that halts bleeding almost entirely. They are typically used short-term — often for three to six months — as a bridge to surgery, to treat co-existing fibroids, or to allow iron stores to recover before a planned procedure. Because they induce menopausal symptoms and accelerate bone loss, they are almost always prescribed alongside add-back HRT, and they are not intended as a long-term standalone solution.
Hysterectomy
Hysterectomy — surgical removal of the uterus — is the only intervention that guarantees a permanent end to menstrual bleeding, and for women with severe, treatment-resistant heavy bleeding it can be genuinely life-changing. It can be performed via open surgery, laparoscopy, or vaginally depending on clinical factors, and recovery varies accordingly; the ovaries are not always removed, which has significant implications for hormonal health and should be discussed explicitly before any procedure. It is a major operation and typically considered after other options have been tried or ruled out, but it should not be withheld from women who have exhausted alternatives and are significantly affected by their symptoms.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.